All Pharma News
price-trendAsk Us
Casi Pharma announces CNCT19 (CD19 CAR-T) granted ODD by The U.S. FDA

Casi Pharma announces CNCT19 (CD19 CAR-T) granted ODD by The U.S. FDA
PRNEWSWIRE
18 Jan 2022
Share Share
Juventas Cell Therapy closes a $63M funding round

Juventas Cell Therapy closes a $63M funding round
Ben Adams FIERCEBIOTECH
25 Oct 2021
Share Share
Juventas Cell Therapy Closes Series C Financing

Juventas Cell Therapy Closes Series C Financing
DIGITALJOURNAL
20 Jul 2021
Share Share